Dr. Nashat Gabrail, M.D.
Claim this profileGabrail Cancer Center
Expert in Solid Tumors
Expert in Tumors
87 reported clinical trials
126 drugs studied
About Nashat Gabrail, M.D.
Education:
- M.D. from Cairo University Faculty of Medicine, Egypt.
- Completed Residency in Internal Medicine at St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA.
- Undertook a Fellowship in Hematology and Oncology at the University of Texas Health Science Center, San Antonio, TX.
Experience:
- Founder and Medical Director of Gabrail Cancer Center in Canton, Ohio.
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
NTRK1 positive
2Tumors
Global LeaderStage IV
Stage III
NTRK1 positive
Affiliated Hospitals
Clinical Trials Nashat Gabrail, M.D. is currently running
Abemaciclib + Elacestrant
for Brain Metastasis from Breast Cancer
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting1 award Phase 1 & 212 criteria
Zipalertinib + Chemotherapy
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with locally advanced or metastatic NSCLC with EGFR ex20ins mutations.
Recruiting2 awards Phase 313 criteria
More about Nashat Gabrail, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 87 trials as a Principal Investigator · 51 Active Clinical TrialsTreatments Nashat Gabrail, M.D. has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Fluorouracil
- Placebo
- Tucatinib
Breakdown of trials Nashat Gabrail, M.D. has run
Solid Tumors
Tumors
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nashat Gabrail, M.D. specialize in?
Nashat Gabrail, M.D. focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Nashat Gabrail, M.D. currently recruiting for clinical trials?
Yes, Nashat Gabrail, M.D. is currently recruiting for 49 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Nashat Gabrail, M.D. has studied deeply?
Yes, Nashat Gabrail, M.D. has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with Nashat Gabrail, M.D.?
Apply for one of the trials that Nashat Gabrail, M.D. is conducting.
What is the office address of Nashat Gabrail, M.D.?
The office of Nashat Gabrail, M.D. is located at: Gabrail Cancer Center, Canton, Ohio 44718 United States. This is the address for their practice at the Gabrail Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.